Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials

Newly diagnosed multiple myeloma (NDMM) patients treated with immunomodulatory drugs are at high risk of venous thromboembolism (VTE), but data are lacking from large prospective cohorts. We present thrombosis outcome data from Myeloma IX (n = 1936) and Myeloma XI (n = 4358) phase 3 randomized contr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood
Main Authors: Bradbury, Charlotte A., Craig, Zoe, Cook, Gordon, Pawlyn, Charlotte, Cairns, David A., Hockaday, Anna, Paterson, Andrea, Jenner, Matthew W., Jones, John R., Drayson, Mark T., Owen, Roger G., Kaiser, Martin F., Gregory, Walter M., Davies, Faith E., Child, J. Anthony, Morgan, Gareth J., Jackson, Graham H.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2020
Assuntos:
Thrombosis and Hemostasis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7453153/
https://ncbi.nlm.nih.gov/pubmed/32438407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005125
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares